Addressing unmet medical needs in disorders of the complement and coagulation systems
Learn more
Harnessing the catalytic power of proteases
Protease engineering platform
Catalyst Biosciences Announces Chief Financial Officer Transition
FDA Grants Catalyst Biosciences Orphan Drug Designation for MarzAA for the Treatment of Factor VII Deficiency
Catalyst Biosciences to Present at the Cantor Global Healthcare Conference
More news
